Annual SG&A
$4.23 M
-$1.73 M-29.00%
01 December 2023
Summary:
Artelo Biosciences annual selling, general & administrative expenses is currently $4.23 million, with the most recent change of -$1.73 million (-29.00%) on 01 December 2023. During the last 3 years, it has risen by +$2.14 million (+101.81%). ARTL annual SG&A is now -29.00% below its all-time high of $5.96 million, reached on 31 December 2022.ARTL Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$870.00 K
+$43.00 K+5.20%
01 September 2024
Summary:
Artelo Biosciences quarterly selling, general & administrative expenses is currently $870.00 thousand, with the most recent change of +$43.00 thousand (+5.20%) on 01 September 2024. Over the past year, it has dropped by -$246.00 thousand (-22.04%). ARTL quarterly SG&A is now -93.19% below its all-time high of $12.78 million, reached on 01 December 2010.ARTL Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$174.69 M
-$9.12 M-5.51%
01 September 2024
Summary:
Artelo Biosciences TTM selling, general & administrative expenses is currently -$174.69 million, with the most recent change of -$9.12 million (-5.51%) on 01 September 2024. Over the past year, it has dropped by -$178.92 million (-4225.81%). ARTL TTM SG&A is now -1141645.10% below its all-time high of $35.64 million, reached on 01 March 2011.ARTL TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARTL Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -22.0% | -4225.8% |
| 3 y3 years | +101.8% | - | - |
| 5 y5 years | +100.0% | +30.0% | -7337.6% |
ARTL Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -29.0% | +101.8% | -50.3% | +5.2% | -105.3% | at low |
| 5 y | 5 years | -29.0% | +101.8% | -50.3% | +34.0% | -843.6% | at low |
| alltime | all time | -29.0% | >+9999.0% | -93.2% | >+9999.0% | <-9999.0% | at low |
Artelo Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $870.00 K(+5.2%) | $3.90 M(-3.9%) |
| June 2024 | - | $827.00 K(-23.6%) | $4.05 M(-4.8%) |
| Mar 2024 | - | $1.08 M(-3.0%) | $4.26 M(+0.6%) |
| Dec 2023 | $4.23 M(-29.0%) | $1.12 M(+8.5%) | $4.23 M(-13.0%) |
| Sept 2023 | - | $1.03 M(-0.3%) | $4.87 M(-5.6%) |
| June 2023 | - | $1.03 M(-2.4%) | $5.16 M(-6.9%) |
| Mar 2023 | - | $1.06 M(-39.6%) | $5.54 M(-7.1%) |
| Dec 2022 | $5.96 M(+184.2%) | $1.75 M(+33.0%) | $5.96 M(+8.6%) |
| Sept 2022 | - | $1.32 M(-7.0%) | $5.49 M(+0.8%) |
| June 2022 | - | $1.42 M(-4.5%) | $5.45 M(+2.2%) |
| Mar 2022 | - | $1.48 M(+15.9%) | $5.33 M(+5.5%) |
| Dec 2021 | $2.10 M(-54.4%) | - | - |
| Nov 2021 | - | $1.28 M(+0.6%) | $5.05 M(+9.5%) |
| Aug 2021 | $4.60 M(+66.3%) | $1.27 M(-2.2%) | $4.62 M(+12.6%) |
| May 2021 | - | $1.30 M(+8.0%) | $4.10 M(+17.4%) |
| Feb 2021 | - | $1.20 M(+43.2%) | $3.49 M(+18.9%) |
| Nov 2020 | - | $841.00 K(+11.3%) | $2.94 M(+6.2%) |
| Aug 2020 | $2.77 M(+30.7%) | $755.50 K(+9.1%) | $2.77 M(+1.3%) |
| May 2020 | - | $692.70 K(+6.7%) | $2.73 M(-2.3%) |
| Feb 2020 | - | $649.10 K(-3.0%) | $2.79 M(+15.8%) |
| Nov 2019 | - | $669.40 K(-7.0%) | $2.41 M(+14.0%) |
| Aug 2019 | $2.12 M(+93.6%) | $719.50 K(-4.9%) | $2.12 M(+20.6%) |
| May 2019 | - | $756.80 K(+182.5%) | $1.76 M(+31.1%) |
| Feb 2019 | - | $267.90 K(-28.1%) | $1.34 M(+9.6%) |
| Nov 2018 | - | $372.80 K(+4.3%) | $1.22 M(+11.8%) |
| Aug 2018 | $1.09 M | $357.60 K(+4.9%) | $1.09 M(+28.4%) |
| May 2018 | - | $340.90 K(+125.9%) | $851.30 K(+40.5%) |
| Feb 2018 | - | $150.90 K(-38.1%) | $606.10 K(+29.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2017 | - | $243.90 K(+111.0%) | $467.20 K(+100.7%) |
| Aug 2017 | $232.80 K(+683.8%) | $115.60 K(+20.8%) | $232.80 K(+91.6%) |
| May 2017 | - | $95.70 K(+697.5%) | $121.50 K(+294.5%) |
| Feb 2017 | - | $12.00 K(+26.3%) | $30.80 K(+28.9%) |
| Nov 2016 | - | $9500.00(+120.9%) | $23.90 K(-19.3%) |
| Aug 2016 | $29.70 K(+95.4%) | $4300.00(-14.0%) | $29.60 K(-1.0%) |
| May 2016 | - | $5000.00(-2.0%) | $29.90 K(+9.1%) |
| Feb 2016 | - | $5100.00(-66.4%) | $27.40 K(-3.9%) |
| Nov 2015 | - | $15.20 K(+230.4%) | $28.50 K(+86.3%) |
| Aug 2015 | $15.20 K(-0.7%) | $4600.00(+84.0%) | $15.30 K(+36.6%) |
| May 2015 | - | $2500.00(-59.7%) | $11.20 K(-33.3%) |
| Feb 2015 | - | $6200.00(+210.0%) | $16.80 K(-2.3%) |
| Nov 2014 | - | $2000.00(+300.0%) | $17.20 K(+13.2%) |
| Aug 2014 | $15.30 K | $500.00(-93.8%) | $15.20 K(+3.4%) |
| May 2014 | - | $8100.00(+22.7%) | $14.70 K(+122.7%) |
| Feb 2014 | - | $6600.00(-99.9%) | $6600.00(-100.0%) |
| June 2011 | - | $7.50 M(-2.8%) | $35.60 M(-0.1%) |
| Mar 2011 | - | $7.71 M(-39.6%) | $35.64 M(+1.8%) |
| Dec 2010 | - | $12.78 M(+68.0%) | $35.02 M(+19.3%) |
| Sept 2010 | - | $7.61 M(+0.8%) | $29.37 M(+3.1%) |
| June 2010 | - | $7.54 M(+6.3%) | $28.49 M(+3.4%) |
| Mar 2010 | - | $7.10 M(-0.4%) | $27.56 M(+1.9%) |
| Dec 2009 | - | $7.12 M(+5.9%) | $27.04 M(+1.8%) |
| Sept 2009 | - | $6.73 M(+1.7%) | $26.56 M(+3.3%) |
| June 2009 | - | $6.62 M(+0.6%) | $25.72 M(+34.6%) |
| Mar 2009 | - | $6.58 M(-0.9%) | $19.10 M(+52.5%) |
| Dec 2008 | - | $6.64 M(+12.9%) | $12.52 M(+112.9%) |
| Sept 2008 | - | $5.88 M | $5.88 M |
FAQ
- What is Artelo Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Artelo Biosciences?
- What is Artelo Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Artelo Biosciences?
- What is Artelo Biosciences quarterly SG&A year-on-year change?
- What is Artelo Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Artelo Biosciences?
- What is Artelo Biosciences TTM SG&A year-on-year change?
What is Artelo Biosciences annual selling, general & administrative expenses?
The current annual SG&A of ARTL is $4.23 M
What is the all time high annual SG&A for Artelo Biosciences?
Artelo Biosciences all-time high annual selling, general & administrative expenses is $5.96 M
What is Artelo Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of ARTL is $870.00 K
What is the all time high quarterly SG&A for Artelo Biosciences?
Artelo Biosciences all-time high quarterly selling, general & administrative expenses is $12.78 M
What is Artelo Biosciences quarterly SG&A year-on-year change?
Over the past year, ARTL quarterly selling, general & administrative expenses has changed by -$246.00 K (-22.04%)
What is Artelo Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of ARTL is -$174.69 M
What is the all time high TTM SG&A for Artelo Biosciences?
Artelo Biosciences all-time high TTM selling, general & administrative expenses is $35.64 M
What is Artelo Biosciences TTM SG&A year-on-year change?
Over the past year, ARTL TTM selling, general & administrative expenses has changed by -$178.92 M (-4225.81%)